Skip to main content

Lateral Dx

Lateral Dx Moves To New Facility to Accommodate COVID-19 Demand

By Marketing Team
Friday, December 18, 2020

We have expanded our business with a new facility to accommodate COVID-19 demand.

2020 has been the year where rapid lateral flow testing hit the mainstream media. The risk of a pandemic virus had been predicted but it was hard to imagine how deeply it would affect our lives.

Suddenly with the SARS Cov-2 pandemic lateral flow rapid testing became the go-to topic of conversation, even outside of our industry.

Here at Lateral Dx, amidst the chaos of the pandemic, our business has grown to accommodate the demand for rapid testing solutions. We are honoured to be part of the global effort to fight COVID-19 and have been busier than ever before supporting our customers in the development of antigen and antibody rapid tests for Coronavirus. 

We have responded to demand and purchased new high-tech equipment to expand our capabilities and have moved to a new larger facility based in Cooperage Way, Alloa, Scotland. This new premises will accommodate our growing team and allow us to further fulfil the increase in development demand for the lateral flow test technology. 

If you need support in lateral flow test development within the field of Coronavirus or elsewhere, please get in touch with our team.

Return to index